Which funds hold Kardium?
From the SEC Form N-PORT filings of US funds, periods ended 2026-05-31 to 2026-07-31
On their latest SEC filings, 20 US funds held Kardium, worth $168 million in all. Select Medical Technology and Devices Portfolio (FSMEX) held the most: $31.1 million, 1.04% of the fund, for the period ended May 31, 2026. The funds that give a share count valued one share at $0.4800 to $1.07, $0.8192 at the median. The first fund to report it held it in Q3 2019; 20 held it in Q2 2026.
The figures by quarter
| Quarter | Funds | Value held |
|---|---|---|
| Q2 2026 | 20 | $168M |
| Q1 2026 | 23 | $210M |
| Q4 2025 | 24 | $210M |
| Q3 2025 | 24 | $213M |
| Q2 2025 | 23 | $214M |
| Q1 2025 | 19 | $121M |
| Q4 2024 | 20 | $120M |
| Q3 2024 | 20 | $121M |
| Q2 2024 | 18 | $88.7M |
| Q1 2024 | 16 | $90.6M |
| Q4 2023 | 16 | $99.1M |
| Q3 2023 | 16 | $112M |
| Q2 2023 | 16 | $112M |
| Q1 2023 | 16 | $112M |
| Q4 2022 | 16 | $107M |
| Q3 2022 | 16 | $107M |
| Q2 2022 | 16 | $107M |
| Q1 2022 | 16 | $113M |
| Q4 2021 | 16 | $113M |
| Q3 2021 | 16 | $113M |
| Q2 2021 | 16 | $113M |
| Q1 2021 | 16 | $113M |
| Q4 2020 | 5 | $18.4M |
| Q3 2020 | 5 | $13.6M |
| Q2 2020 | 5 | $13.6M |
| Q1 2020 | 5 | $13.7M |
| Q4 2019 | 5 | $18.4M |
| Q3 2019 | 4 | $17.9M |
Every fund holding Kardium
Largest stake first. The value per share is the fund's value divided by its number of shares, for a fund that gives one; a fund that holds several series of shares can value each one differently.
| Fund | Value | Of the fund | Per share | Period ended |
|---|---|---|---|---|
| Select Medical Technology and Devices Portfolio FSMEXSeries E preferred · filing | $31.1M | 1.04% | $0.8500 to $1.07 | 2026-05-31 |
| T. Rowe Price Health Sciences Fund, Inc. PRHSX, THISXSeries D6 preferred, Series D-7 preferred, Series D-5 preferred and 1 more · filing | $29.6M | 0.25% | $0.6472 to $0.8274 | 2026-06-30 |
| T. Rowe Price New Horizons Fund, Inc. PRJIX, PRNHXSeries D6 preferred, Series D-5 preferred · filing | $22.8M | 0.15% | $0.8192 to $0.8274 | 2026-06-30 |
| Fidelity Growth Company Fund FDGRX, FGCKXSeries E preferred · filing | $19.1M | 0.02% | $0.5200 to $1.07 | 2026-05-31 |
| T. Rowe Price Small-Cap Stock Fund, Inc. OTCFX, OTIIXSeries D-7 preferred, Series D6 preferred, Series D-8 preferred · filing | $15.8M | 0.17% | $0.6472 to $0.8274 | 2026-06-30 |
| Eventide Healthcare & Life Sciences Fund ETAHX, ETCHXPreferred shares · filing | $10.8M | 0.60% | $0.7000 | 2026-06-30 |
| Select Health Care Portfolio FHCLX, FHCNXSeries E preferred · filing | $10.4M | 0.18% | $0.5200 | 2026-05-31 |
| T. Rowe Price Institutional Small-Cap Stock Fund TRSSXSeries D-7 preferred, Series D6 preferred, Series D-8 preferred · filing | $8.1M | 0.16% | $0.6472 to $0.8274 | 2026-06-30 |
| Fidelity Advisor Health Care Fund FACDX, FACTXSeries E preferred · filing | $6.0M | 0.19% | $0.4800 to $0.4900 | 2026-07-31 |
| Fidelity Growth Company K6 Fund FGKFXSeries E preferred · filing | $4.8M | 0.02% | $0.5200 to $1.07 | 2026-05-31 |
| Fidelity Series Growth Company Fund FCGSXSeries E preferred · filing | $4.1M | 0.02% | $0.5200 to $1.07 | 2026-05-31 |
| VIP Health Care PortfolioSeries E preferred · filing | $1.6M | 0.14% | $0.5200 | 2026-06-30 |
| T. Rowe Price Health Sciences Portfolio QAAGZX, QAAHBXSeries D6 preferred, Series D-7 preferred, Series D-5 preferred and 1 more · filing | $1.4M | 0.19% | $0.6472 to $0.8274 | 2026-06-30 |
| VIP Stock Selector PortfolioSeries E preferred · filing | $785,086 | 0.02% | $0.5200 | 2026-06-30 |
| Science & Technology Fund VCSTXSeries D preferred · filing | $555,257 | 0.01% | $1.02 | 2026-05-31 |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund TGIPX, TRSGXSeries D-7 preferred, Series D-8 preferred, Series D6 preferred · filing | $384,416 | 0.01% | $0.6472 to $0.8274 | 2026-05-31 |
| T. Rowe Price Spectrum Moderate Allocation Fund TPPAX, TRPBXSeries D-7 preferred, Series D6 preferred, Series D-8 preferred · filing | $183,391 | 0.01% | $0.6472 to $0.8274 | 2026-05-31 |
| T. Rowe Price Spectrum Conservative Allocation Fund PPIPX, PRSIXSeries D-7 preferred, Series D6 preferred, Series D-8 preferred · filing | $117,680 | 0.01% | $0.6472 to $0.8274 | 2026-05-31 |
| Small Cap Growth Fund VVSGXSeries D6 preferred · filing | $60,238 | 0.01% | $1.02 | 2026-05-31 |
| T. Rowe Price Moderate Allocation Portfolio QAAGRXSeries D-7 preferred, Series D-8 preferred, Series D6 preferred · filing | $16,721 | 0.01% | $0.6472 to $0.8274 | 2026-06-30 |
Other private companies US funds hold
- Anthropic 110 funds
- Databricks 98 funds
- Sila Nanotechnologies 23 funds
- Fanatics 21 funds
- Lightmatter 20 funds
- Tenstorrent 20 funds
- ElevateBio 20 funds
- Long Wall (ABL Space Systems) 20 funds
Where these figures come from
A holding is a fund's common or preferred share of a company that is not listed: valued with unobservable inputs (fair value level 3) and placed privately (a restricted security, or PP in its title), never a right left from a takeover, an escrow, or a vehicle that holds such shares. A company that funds hold as a listed share in the same data set is public and left out. Rows are joined into a company by its name, its share class and legal form cut off. Each fund values its shares itself, every quarter, so two funds can value one share differently.
Each row is a fund's latest public Form N-PORT. The other private companies US funds hold are on the list of private companies.
Use this data
Every holder, its filing and the history by quarter since 2019 are in kardium.json, and every company in the list's file. Free with credit under CC BY 4.0, like the rest of the API.
Cite this page
TickerInside, funds holding Kardium, from SEC Form N-PORT (2026q3 data set), https://tickerinside.com/private-companies/kardium/
Each value is the fund's own estimate of a share no market quotes, from its latest public SEC Form N-PORT. Measurements of public filings, not investment advice and not a way to buy a share.
